These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36528490)

  • 1. USP22 Contributes to Chemoresistance, Stemness, and EMT Phenotype of Triple-Negative Breast Cancer Cells by egulating the Warburg Effect via c-Myc Deubiquitination.
    Li J; Gao R; Zhang J
    Clin Breast Cancer; 2023 Feb; 23(2):162-175. PubMed ID: 36528490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Notch1 reverses EMT and chemoresistance to cisplatin via direct downregulation of MCAM in triple-negative breast cancer cells.
    Zeng D; Liang YK; Xiao YS; Wei XL; Lin HY; Wu Y; Bai JW; Chen M; Zhang GJ
    Int J Cancer; 2020 Jul; 147(2):490-504. PubMed ID: 32020593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADAM9 deubiquitination induced by USP22 suppresses proliferation, migration, invasion, and epithelial-mesenchymal transition of trophoblast cells in preeclampsia.
    Liu J; Wang Y; Zhang S; Sun L; Shi Y
    Placenta; 2024 Feb; 146():50-57. PubMed ID: 38176298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer.
    Serrano-Oviedo L; Nuncia-Cantarero M; Morcillo-Garcia S; Nieto-Jimenez C; Burgos M; Corrales-Sanchez V; Perez-Peña J; Győrffy B; Ocaña A; Galán-Moya EM
    Cell Oncol (Dordr); 2020 Jun; 43(3):431-444. PubMed ID: 32166583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SRSF1 inhibits ferroptosis and reduces cisplatin chemosensitivity of triple-negative breast cancer cells through the circSEPT9/GCH1 axis.
    Song X; Wang X; Chen X; Yu Z; Zhou Y
    J Proteomics; 2024 Feb; 292():105055. PubMed ID: 38040194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetrandrine Inhibits Cancer Stem Cell Characteristics and Epithelial to Mesenchymal Transition in Triple-Negative Breast Cancer via SOD1/ROS Signaling Pathway.
    Liu T; Li K; Zhang Z; Peng J; Yang J; Law BYK; Liu X; Li W
    Am J Chin Med; 2023; 51(2):425-444. PubMed ID: 36692485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulforaphane-cisplatin combination inhibits the stemness and metastatic potential of TNBCs via down regulation of sirtuins-mediated EMT signaling axis.
    Sinha S; Sharma S; Sharma A; Vora J; Shrivastava N
    Phytomedicine; 2021 Apr; 84():153492. PubMed ID: 33640782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SCAMP3 promotes breast cancer progression through the c-MYC-β-Catenin-SQSTM1 growth and stemness axis.
    Ali A; Shafarin J; Muhammad JS; Farhat NM; Hamad M; Soofi A; Hamad M
    Cell Signal; 2023 Apr; 104():110591. PubMed ID: 36627007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β plays a vital role in triple-negative breast cancer (TNBC) drug-resistance through regulating stemness, EMT and apoptosis.
    Xu X; Zhang L; He X; Zhang P; Sun C; Xu X; Lu Y; Li F
    Biochem Biophys Res Commun; 2018 Jul; 502(1):160-165. PubMed ID: 29792857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of USP22 reduces cell stemness and enhances the sensitivity of pancreatic cancer cells to cisplatin by inactivating the Wnt/β-catenin pathway.
    Li Z; Huang X; Hu W; Lu H
    Tissue Cell; 2022 Aug; 77():101787. PubMed ID: 35623308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitin-specific protease 22 is critical to in vivo angiogenesis, growth and metastasis of non-small cell lung cancer.
    Zhang K; Yang L; Wang J; Sun T; Guo Y; Nelson R; Tong TR; Pangeni R; Salgia R; Raz DJ
    Cell Commun Signal; 2019 Dec; 17(1):167. PubMed ID: 31842906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. USP1-mediated deubiquitination of KDM1A promotes the malignant progression of triple-negative breast cancer.
    Su Y; Du Y; He W
    J Biochem Mol Toxicol; 2024 Oct; 38(10):e23864. PubMed ID: 39318028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasma exosomal miR-335-5p serves as a diagnostic indicator and inhibits immune escape in triple-negative breast cancer].
    Chen T; Dong Y; Wu X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Apr; 38(4):347-356. PubMed ID: 35583065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA1-IRIS overexpression promotes and maintains the tumor initiating phenotype: implications for triple negative breast cancer early lesions.
    Sinha A; Paul BT; Sullivan LM; Sims H; El Bastawisy A; Yousef HF; Zekri AN; Bahnassy AA; ElShamy WM
    Oncotarget; 2017 Feb; 8(6):10114-10135. PubMed ID: 28052035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NOTCH4 maintains quiescent mesenchymal-like breast cancer stem cells via transcriptionally activating SLUG and GAS1 in triple-negative breast cancer.
    Zhou L; Wang D; Sheng D; Xu J; Chen W; Qin Y; Du R; Yang X; He X; Xie N; Liu S; Zhang L
    Theranostics; 2020; 10(5):2405-2421. PubMed ID: 32104513
    [No Abstract]   [Full Text] [Related]  

  • 16. Operative ubiquitin-specific protease 22 deubiquitination confers a more invasive phenotype to cholangiocarcinoma.
    Tian Y; Tang B; Wang C; Wang Y; Mao J; Yao Y; Gao Z; Liang R; Ye M; Cai S; Wang L
    Cell Death Dis; 2021 Jul; 12(7):678. PubMed ID: 34226501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066.
    Cheng CC; Shi LH; Wang XJ; Wang SX; Wan XQ; Liu SR; Wang YF; Lu Z; Wang LH; Ding Y
    Int J Oncol; 2018 Jul; 53(1):339-348. PubMed ID: 29750424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hydnocarpin inhibits malignant progression of triple negative breast cancer via CNOT4-mediated ubiquitination and degradation of YAP].
    Ou HL; Wu H; Ren YL; Si Y; Duan ZQ; Liu XW
    Zhongguo Zhong Yao Za Zhi; 2023 Aug; 48(16):4483-4492. PubMed ID: 37802875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA UBAP2 facilitates the cisplatin resistance of triple-negative breast cancer via microRNA-300/anti-silencing function 1B histone chaperone/PI3K/AKT/mTOR axis.
    Wang L; Yang X; Zhou F; Sun X; Li S
    Bioengineered; 2022 Mar; 13(3):7197-7208. PubMed ID: 35263216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. USP22 promotes hypoxia-induced hepatocellular carcinoma stemness by a HIF1α/USP22 positive feedback loop upon TP53 inactivation.
    Ling S; Shan Q; Zhan Q; Ye Q; Liu P; Xu S; He X; Ma J; Xiang J; Jiang G; Wen X; Feng Z; Wu Y; Feng T; Xu L; Chen K; Zhang X; Wei R; Zhang C; Cen B; Xie H; Song P; Liu J; Zheng S; Xu X
    Gut; 2020 Jul; 69(7):1322-1334. PubMed ID: 31776228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.